These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18823442

  • 1. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q, Jiang XH, Zheng MH, Chen YP.
    J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
    [Abstract] [Full Text] [Related]

  • 2. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.
    Bai M, Yang Z, Qi X, Fan D, Han G.
    J Gastroenterol Hepatol; 2013 May; 28(5):783-92. PubMed ID: 23425108
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
    Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P.
    Liver Int; 2010 Apr; 30(4):574-82. PubMed ID: 20456040
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV, Sharma BC, Sharma P, Sarin SK.
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.
    He Q, Mao C, Chen Z, Zeng Y, Deng Y, Hu R.
    Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
    Butterworth RF, McPhail MJW.
    Drugs; 2019 Feb; 79(Suppl 1):31-37. PubMed ID: 30706425
    [Abstract] [Full Text] [Related]

  • 14. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
    Krüger B, Held C, Kircheis G.
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
    [No Abstract] [Full Text] [Related]

  • 15. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
    Ndraha S, Simadibrata M.
    Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M, Li L, Lu CZ, Cao WK.
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [Abstract] [Full Text] [Related]

  • 17. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Görtelmeyer R, Hendricks R, Heuser A, Karoff C, Malfertheiner P, Mayer D, Rösch W, Steffens J.
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
    Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS.
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.